Lucira Health Stock Soars After Q2 Sales Jump 175% Sequentially
Lucira Health Inc (NASDAQ:LHDX) reported sales of $12.4 million in Q2, the firm’s second full quarter of commercial activity, beating the…
Lucira Health Q2 EPS $(0.42) Misses $(0.32) Estimate, Sales $12.40M Beat $8.00M Estimate
Lucira Health (NASDAQ:LHDX) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.32) by 31.25 percent. The company reported quarterly sales of $12.40 million which beat the
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 11)
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell
• Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
85 Biggest Movers From Yesterday
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
64 Biggest Movers From Friday
Gainers
Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share.
52 Biggest Movers From Yesterday
Gainers
Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA, its distinctive immuno-oncology RNA therapy for the treatment of multiple cancers.